Yu-yan Xiong
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
CRP Cutoff Value in East Asians With Coronary Heart Disease: A Systematic Review and Meta-Analysis.
Journal: JACC. Asia
Published: October 23, 2025
Nicorandil-Pretreated Mesenchymal Stem Cell-Derived Exosomes Facilitate Cardiac Repair After Myocardial Infarction via Promoting Macrophage M2 Polarization by Targeting miR-125a-5p/TRAF6/IRF5 Signaling Pathway.
Journal: International journal of nanomedicine
Published: September 20, 2023
Levosimendan Reverses Cardiac Malfunction and Cardiomyocyte Ferroptosis During Heart Failure with Preserved Ejection Fraction via Connexin 43 Signaling Activation.
Journal: Cardiovascular drugs and therapy
Published: February 13, 2023
Nanoparticles: Promising Tools for the Treatment and Prevention of Myocardial Infarction.
Journal: International journal of nanomedicine
Published: July 13, 2021
The Vital Roles of Mesenchymal Stem Cells and the Derived Extracellular Vesicles in Promoting Angiogenesis After Acute Myocardial Infarction.
Journal: Stem cells and development
Published: March 23, 2021
The pivotal roles of exosomes derived from endogenous immune cells and exogenous stem cells in myocardial repair after acute myocardial infarction.
Journal: Theranostics
Published: September 16, 2020
Transplantation efficacy of autologous bone marrow mesenchymal stem cells combined with atorvastatin for acute myocardial infarction (TEAM-AMI): rationale and design of a randomized, double-blind, placebo-controlled, multi-center, Phase II TEAM-AMI trial.
Journal: Regenerative medicine
Published: December 13, 2019
Optimization of Timing and Times for Administration of Atorvastatin-Pretreated Mesenchymal Stem Cells in a Preclinical Model of Acute Myocardial Infarction.
Journal: Stem cells translational medicine
Published: January 11, 2019
Regulation of Type 2 Immunity in Myocardial Infarction.
Journal: Frontiers in immunology
Published: November 27, 2018
Combined therapy with atorvastatin and atorvastatin-pretreated mesenchymal stem cells enhances cardiac performance after acute myocardial infarction by activating SDF-1/CXCR4 axis.
Journal: American journal of translational research
Published: November 20, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026